Literature DB >> 8587305

[Clinicopathologic study of 817 enucleations].

N Gassler1, P K Lommatzsch.   

Abstract

METHODS: The clinical findings, the indications for enucleation and the histopathological diagnoses from 817 eyes from the University Eye Hospital in Leipzig, enucleated between 01/01/1980 and 31/12/1989 (433 males; 384 females), were analysed retrospectively to investigate, however, the therapeutic and diagnostic importance of enucleation to ophthalmological problems.
RESULTS: The most frequent underlying ocular diseases were: intraocular tumour (47.7%), surgical disease [primary glaucoma, retinal detachment, cataract] (18.6%), trauma [enucleation within 4 weeks after the event] (10.3%), systemic disease (6.6%), inflammation (6.1%), other diseases (10.7%). The final causes for enucleation were: intraocular tumour (46.4%), secondary glaucoma (31.6%), atrophia and phthisis bulbi (11.9%), inflammation (6.5%), trauma (0.9%), other diseases (2.7%). An increase in the enucleation rate was noted with increasing age. The ophthalmoscopic diagnoses of 8 i.o. malignant melanomas and 7 cases of retinoblastoma were histopathologically not verified. The histopathological diagnoses included: exudative-hemorrhagic lesion (7), metastasis (1) respectively M. Coats (3), retinal detachment (2), M. Norrie (1), panophthalmitis (1). In 2 cases of i.o. malignant melanoma and 2 cases of retinoblastoma the tumours were clinically unsuspected. The incorrect clinical diagnoses included: secondary glaucoma (2) respectively M. Coats (1), secondary glaucoma (1).

Entities:  

Mesh:

Year:  1995        PMID: 8587305     DOI: 10.1055/s-2008-1035382

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  2 in total

Review 1.  [Histological diagnostics of enucleated eyes].

Authors:  S Koinzer; K Löffler
Journal:  Pathologe       Date:  2015-07       Impact factor: 1.011

Review 2.  Survey on the management of orbital and intraocular tumors among oculofacial surgeons in the Asia-Pacific region.

Authors:  Priscilla Xinhui Wang; Victor Teck Chang Koh; Katherine Lun; Gangadhara Sundar
Journal:  Int Ophthalmol       Date:  2013-10-02       Impact factor: 2.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.